MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), t...
Continue Reading →
